You can buy or sell PerkinElmer and other stocks, options, ETFs, and crypto commission-free!
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following two segments: Discovery & Analytical Solutions, and Diagnostics. Read More The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
52 Week High
52 Week Low
Stock to Watch: PerkinElmer (NYSE: PKI)
PerkinElmer is in the medical diagnostics and research industry and is part of the healthcare sector. The company CEO is Robert F. Friel. PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery and Analytical Solutions and Diagnostics. Previous Intraday Trading Performance: The PKI stock showed a previous change of -0.01% with an open at 94.40 and a close of 94.03. ...
Simply Wall StMar 11
Does PerkinElmer, Inc.’s (NYSE:PKI) CEO Salary Reflect Performance?
Rob Friel has been the CEO of PerkinElmer, Inc. (NYSE:PKI) since 2008. First, this article will compare CEO compensation with compensation at other large companies. After that, we will consider the growth in the business. Third, we’ll reflect on the total return to shareholders over three years, as a second measure of business performance. This process should give us an idea about how appropriately the CEO is paid. See our latest analysis for PerkinElmer How Does Rob Friel’s Compensation Compare With Simi...
Current Fundamentals: PerkinElmer (NYSE: PKI)
PerkinElmer is part of the healthcare sector and is in the medical diagnostics and research industry. The company CEO is Robert F. Friel. PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery and Analytical Solutions and Diagnostics. Previous Intraday Trading Performance: The PKI stock showed a previous change of -0.77% with an open at 97.27 and a close of 95.72. ...
Expected Apr 29, After Hours